Clinical trial
Effects of Mirtazapine on Appetite in Advanced Cancer Patients
NCT00488072 · M.D. Anderson Cancer Center, Other · Active, not recruiting
Key facts
| NCT number | NCT00488072 |
|---|---|
| Title | Effects of Mirtazapine on Appetite in Advanced Cancer Patients |
| Official title | Preliminary Study to Explore the Effects of Mirtazapine on Appetite in Advanced Cancer Patients |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Cancer, Anorexia, Weight Loss, Insomnia |
| Intervention type | Drug |
| Interventions | Mirtazapine, Placebo |
| Enrollment | 98 |
| Start date | Jan 8, 2007 |
| Primary completion | Dec 31, 2027 |
| Completion | Dec 31, 2027 |
| First posted | Jun 19, 2007 |
| Last update posted | Jan 26, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: